Górka Z, Maj J
Pol J Pharmacol Pharm. 1986 Sep-Dec;38(5-6):493-9.
Imipramine, amitriptyline, citalopram, zimelidine and mianserin--antidepressant drugs with a different mechanism of pharmacological activity, as well as haloperidol, a neuroleptic, and diazepam, an anxiolytic, administered for 14 days, were examined in photoresistor actometers in the exploratory activity test (within the first 60 min) and in the basic locomotor activity test (the following 11 h) in the light and dark phases of the LD 12:12 cycle. Imipramine had no effect on the exploratory activity in either phase of the cycle, yet it enhanced the basic locomotor activity in the light phase. Amitriptyline stimulated only the exploratory activity in the dark phase. Citalopram enhanced the exploratory activity in both phases and did not change the basic locomotor activity in either phase of the cycle. Zimelidine increased the exploratory activity in the dark phase and inhibited the basic locomotor activity in both phases. Mianserin stimulated the exploratory activity in the dark phase and the basic locomotor activity in the light one, yet it inhibited the latter in the dark phase. Haloperidol attenuated the exploratory activity in both phases and the basic locomotor activity in the light phase. Diazepam enhanced the exploratory activity in both phases, exerting no effect on the basic locomotor activity. The results indicate that the examined antidepressant drugs administered repeatedly exert a diversified effect on the exploratory activity and the basic locomotor activity in the dark and light phases, yet the dominating feature is the increased exploratory activity in the dark phase.
丙咪嗪、阿米替林、西酞普兰、齐美利定和米安色林——具有不同药理活性机制的抗抑郁药物,以及氟哌啶醇(一种抗精神病药物)和地西泮(一种抗焦虑药物),连续给药14天,在LD 12:12周期的光照和黑暗阶段,通过光电电阻活动计在探索性活动测试(最初60分钟内)和基本运动活动测试(接下来11小时)中进行检测。丙咪嗪在周期的任何一个阶段对探索性活动均无影响,但它增强了光照阶段的基本运动活动。阿米替林仅刺激黑暗阶段的探索性活动。西酞普兰在两个阶段均增强了探索性活动,且在周期的任何一个阶段均未改变基本运动活动。齐美利定增加了黑暗阶段的探索性活动,并在两个阶段均抑制了基本运动活动。米安色林刺激黑暗阶段的探索性活动以及光照阶段的基本运动活动,但在黑暗阶段抑制后者。氟哌啶醇在两个阶段均减弱了探索性活动以及光照阶段的基本运动活动。地西泮在两个阶段均增强了探索性活动,对基本运动活动无影响。结果表明,反复给药的受试抗抑郁药物对黑暗和光照阶段的探索性活动和基本运动活动具有多样化的影响,但主要特征是黑暗阶段探索性活动增加。